JocelynALewisDO(She/Her)
Pediatric Hematology & Oncology • Stamford, CTPediatric Hematologic Oncology, Pediatric Sarcoma Oncology, Pediatric Solid Tumor Oncology
Medical Director Clinical Development at SpringWorks Therapeutics
Dr. Lewis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Springworks Therapeutics
100 Washington Blvd
Stamford, CT 06902
Summary
- Board certified pediatric hematologist/oncologist working in biotech to advance the science of curing cancer.
Education & Training
Medical University of South CarolinaFellowship, Pediatric Hematology/Oncology, 2007 - 2010
University of MarylandResidency, Pediatrics, 2004 - 2007
Kansas City University of Medicine and Biosciences College of Osteopathic MedicineClass of 2003
Goucher CollegeBA, Biological Sciences, 1994 - 1998
Certifications & Licensure
NJ State License 2013 - 2025
PA State License 2020 - 2022
TN State License 2010 - 2014
SC State License 2007 - 2011
Awards, Honors, & Recognition
- Go Getter Award SpringWorks Therapeutics, 2022
Clinical Trials
- Nirogacestat in Ovarian Granulosa Cell Tumors Start of enrollment: 2022 Aug 30
Publications & Presentations
PubMed
- 5 citationsDefinition of cortical bone involvement in the staging of newly diagnosed pediatric Hodgkin lymphoma: A report from the International Working Group on Staging Evaluati...Jocelyn Lewis, Kathleen M. McCarten, Lars Kurch, Jamie E. Flerlage, Sue C. Kaste
Pediatric Blood & Cancer. 2020-04-01 - 34 citationsStaging Evaluation and Response Criteria Harmonization (SEARCH) for Childhood, Adolescent and Young Adult Hodgkin Lymphoma (CAYAHL): Methodology statement.Jamie E. Flerlage, Kara M. Kelly, Auke Beishuizen, Steve Y. Cho, Pedro A. de Alarcon
Pediatric Blood & Cancer. 2017-07-01 - 33 citationsOff-Target Function of the Sonic-Hedgehog Inhibitor Cyclopamine in Mediating Apoptosis via Nitric Oxide-Dependent Neutral Sphingomyelinase 2/Ceramide InductionMarisa Meyers-Needham, Jocelyn A. Lewis, Salih Gencer, R. David Sentelle, Sahar A. Saddoughi
Molecular Cancer Therapeutics. 2012-05-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
